Literature DB >> 2708386

Phosphorylation of caldesmon in arterial smooth muscle.

L P Adam1, J R Haeberle, D R Hathaway.   

Abstract

We have isolated caldesmon (Mr = 145,000), by immunoprecipitation, from [32P]orthophosphate-loaded porcine carotid arteries. In resting muscles, caldesmon was phosphorylated to 0.45 mol of PO4/mol protein, while the 20,000-dalton myosin regulatory light chain (LC20) was phosphorylated to less than 0.05 mol/mol. After stimulation by KCl (110 mM) for 75 min and phorbol 12,13-dibutyrate (PDBu, 1 microM) for 60 min, caldesmon phosphorylation levels rose to 0.96 and 1.1 mol/mol, respectively. LC20 phosphorylation increased to 0.49 mol/mol at 1 min of stimulation by KCl and decreased to 0.17 mol/mol at 60 min. With PDBu, phosphate incorporation into LC20 rose only slightly, reaching 0.09 mol/mol after 90 min. Muscles contracted with histamine (10 microM) or ouabain (1 microM) also demonstrated elevated levels of phosphate incorporation into caldesmon. In these muscles, LC20 phosphorylation levels were less than 0.05 mol/mol. Three major phosphopeptides of indistinguishable mobility were identified on maps of caldesmon from resting, KCl-stimulated, and PDBu-stimulated muscles. There was, however, little similarity between the phosphopeptide maps of caldesmon phosphorylated in intact tissue and maps of purified caldesmon phosphorylated in vitro by protein kinase C (Ca2+/phospholipid-dependent enzyme) or Ca2+/calmodulin kinase II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Thin-filament linked regulation of smooth muscle myosin.

Authors:  J R Haeberle
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

Review 2.  Vascular smooth muscle contractile elements. Cellular regulation.

Authors:  J T Stull; P J Gallagher; B P Herring; K E Kamm
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

Review 3.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

4.  Cytoskeletal targeting of calponin in differentiated, contractile smooth muscle cells of the ferret.

Authors:  C A Parker; K Takahashi; J X Tang; T Tao; K G Morgan
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

5.  Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.

Authors:  Z Wang; H Jiang; Z Q Yang; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

6.  Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.

Authors:  Anita Kása; Csilla Csortos; Alexander D Verin
Journal:  Tissue Barriers       Date:  2015-04-03

7.  Ca2+ regulation of the contractile apparatus in canine gastric smooth muscle.

Authors:  H Ozaki; W T Gerthoffer; M Hori; H Karaki; K M Sanders; N G Publicover
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

8.  Sensitization of the contractile system of canine colonic smooth muscle by agonists and phorbol ester.

Authors:  K Sato; R Leposavic; N G Publicover; K M Sanders; W T Gerthoffer
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

9.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

10.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.